logo Kompas.id
EnglishEfficacy, Effectiveness and Immunogenicity

Efficacy, Effectiveness and Immunogenicity

Various questions have emerged regarding the low efficacy of CoronaVac, the Covid-19 vaccine produced by Sinovac Biotech China, in Phase III of the clinical trials in Indonesia compared to in other countries.

Oleh Atika Walujani Moedjiono
· 0 menit baca
Memuat data...

Medical officers are preparing to administer the CoronaVac vaccine, made by Sinovac Biotech Ltd, a company from China, Wednesday (13/1/2021) at Merdeka Palace, Jakarta. President Joko Widodo became the first person in Indonesia to receive a Covid-19 vaccine injection.

Jadilah Bagian dari Jurnalisme Berkualitas Belum selesai baca berita ini? Selesaikan dengan berlangganan konten digital premium Kompas.
Kompas Digital Premium 1 Bulan
Kompas Digital Premium 1 Bulan
Rp 50.000 /Bulan
BERLANGGANAN
Berita utama
Akses tak terbatas ke seluruh rubrik (termasuk ePaper)
Tanpa diskon
POPULER
Kompas Digital Premium 12 Bulan (Hemat 40%)
Kompas Digital Premium 12 Bulan (Hemat 40%)
Rp 360.000 /Tahun
BERLANGGANAN
Berita utama
Akses tak terbatas ke seluruh rubrik (termasuk ePaper)
Hemat 40%
Kompas Digital Premium & Koran
Kompas Digital Premium & Koran
Rp 108.000 /Bulan
BERLANGGANAN
Berita utama
Akses tak terbatas ke seluruh rubrik (termasuk ePaper)
Edisi cetak harian kompas dikirim ke alamat anda
Editor: Syahnan Rangkuti
Memuat data..